KIR/HLA pleiotropism: Protection against both HIV and opportunistic infections
2006

KIR/HLA Protection in HIV Disease

Sample size: 1184 publication 10 minutes Evidence: moderate

Author Information

Author(s): Qi Ying, Martin Maureen P, Gao Xiaojiang, Jacobson Lisa, Goedert James J, Buchbinder Susan, Kirk Gregory D, O'Brien Stephen J, Trowsdale John, Carrington Mary

Primary Institution: Laboratory of Genomic Diversity, SAIC-Frederick, Inc., National Cancer Institute

Hypothesis

Does the compound genotype KIR3DS1/HLA-B Bw4-80I provide protection against HIV disease and opportunistic infections?

Conclusion

The KIR3DS1/Bw4-80I genotype offers dual protection against HIV viral load and opportunistic infections, but not against AIDS-related malignancies.

Supporting Evidence

  • The KIR3DS1/Bw4-80I genotype was associated with lower HIV viral load set points.
  • Protection against opportunistic infections was significant in multiple analyses.
  • No significant protection was observed against AIDS-related malignancies.
  • Adjusting for other protective alleles did not alter the strength of KIR3DS1/Bw4-80I protection.
  • Survival analysis confirmed delayed progression to opportunistic infections.
  • Participants with KIR3DS1/Bw4-80I had a lower risk of developing opportunistic infections.
  • The study included a diverse cohort of HIV-infected individuals.
  • Findings highlight the complex role of host genetics in HIV disease progression.

Takeaway

Some people have a special gene combination that helps them fight off HIV and infections that can happen when your immune system is weak, but it doesn't help with certain cancers.

Methodology

The study analyzed data from 1,184 HIV-1 infected individuals to assess the protective effects of the KIR3DS1/Bw4-80I genotype against AIDS-defining illnesses.

Potential Biases

Potential confounding factors related to the genetic diversity of the populations studied.

Limitations

The study was conducted before the introduction of highly active antiretroviral therapy, which may limit the applicability of the findings to current treatment contexts.

Participant Demographics

The study included 799 European Americans, 332 African Americans, and 53 individuals of other ethnicities.

Statistical Information

P-Value

0.003–0.005

Confidence Interval

OR = 0.36–0.4

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.ppat.0020079

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication